Tildrakizumab for Systemic‐Treatment‐Eligible Plaque Psoriasis: A Retrospective Real‐World Study in Chinese Patients

Dermatologic Therapy · Published 2026-01-01 · DOI 10.1155/dth/9941211

Free full text

Authors being retrieved — see the publisher record. https://doi.org/10.1155/dth/9941211

Abstract

PubPorta does not have an abstract for this article yet.

Read the article at the publisher →

Publication details

Year
2026

Related articles